The endocannabinoid anandamide mediates anti-inflammatory effects through activation of NR4A nuclear receptors.
British journal of pharmacology
View this publicationBritish journal of pharmacology
View this publicationInvestigative radiology
View this publicationRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
View this publicationUrologie (Heidelberg, Germany)
View this publicationJournal of autoimmunity
View this publicationNature communications
View this publicationPLoS pathogens
View this publicationLancet (London, England)
View this publicationNature communications
View this publicationCell reports
View this publication